Skip to main content

Effect of RNA quality on transcript intensity levels in microarray analysis of human post-mortem brain tissues.

Popova T, Mennerich D, Weith A, Quast K

Publication: BMC Genomics (2008) • Vol 9 • Page 91PMID: 18298816View on PubMed

Purpose

The purpose of this paper was to evaluate the effects of post-chip RNA quality (which can be a result of the quality of the starting material and the influence of sample processing) on measured transcript intensities in cDNA microarrays. The paper also evaluated the influence of brain pH, duration of agonal stage, post-mortem interval, and donor age on post-chip RNA quality.

Conclusion

RNA quality can impact the expression profile of 10-30% of chip represented transcripts, with identified sources including probe set distribution and transcript position, and mRNA transcript length and stability. The authors did not identify significant effects on RNA quality with respect to brain pH, duration of agonal stage, post-mortem interval, or donor age. The authors recommend inclusion of chip-specific RNA quality dependency as part of data analysis, and matching sample sets with respect to RNA quality.

Studies (2)

Purpose

The purpose of this study was to evaluate the effects of post-chip RNA quality (which can be a result of the quality of the starting material and the influence of sample processing) on measured transcript intensities in cDNA microarrays. RNA quality was assessed via 5':3' ratios for beta-actin and GAPDH.

Summary of Findings

Differences among the number and distribution of RNA quality-dependent transcripts were found among tissue sets and chip platforms. From results observed, the authors estimate that the expression of 10-30% of chip represented transcripts may correlate to RNA quality; thus, RNA quality can potentially and strongly influence microarray results. Sources of RNA quality-dependent microarray results include probe set position and mRNA transcript length and stability.
  • Biospecimens

    TissueBrain
  • Preservation Types

    Frozen
  • Diagnoses

    Parkinson's Disease
    Not specified
    Autopsy
  • Platforms

    RNADNA microarray
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    DNA microarray SpecificQuality metrics
    <3 3'/5' Ratio (high quality)
    >3 3'/5' Ratio (low quality)
    DNA microarray SpecificTargeted nucleic acid
    GAPDH
    beta-actin